{
    "title": "Drugs giant GSK says encouraging results from hepatitis B treatment trial raise hopes for millions suffering from chronic infection",
    "url": "https://www.dailymail.co.uk/money/markets/article-10952733/Hepatitis-drug-trial-gives-pharmaceutical-giant-GSK-big-boost.html",
    "date": "2022-06-25",
    "keywords": [
        "gsk",
        "treatment",
        "hepatitis",
        "b",
        "bepirovirsen",
        "month",
        "vaccine",
        "share",
        "fund",
        "trial",
        "stage",
        "rsv",
        "elliott",
        "year",
        "money",
        "diy",
        "platform",
        "company",
        "investment",
        "account",
        "fee",
        "infection",
        "boost",
        "development",
        "news",
        "phase",
        "disease",
        "view",
        "approval",
        "end",
        "vital",
        "companys",
        "success",
        "shot",
        "arm",
        "glaxo",
        "victory",
        "article",
        "body",
        "virus",
        "cirrhosis",
        "liver",
        "cancer",
        "midstage",
        "study",
        "curechris",
        "corsico",
        "vice",
        "president",
        "yesterday",
        "executive",
        "dame",
        "walmsley",
        "attack",
        "toothpaste",
        "consumer",
        "healthcare",
        "business",
        "haleon",
        "capital",
        "risk",
        "isa",
        "trade",
        "community",
        "model",
        "affiliate",
        "product",
        "commission",
        "editorial",
        "independence",
        "investing"
    ],
    "category": [
        "money",
        "markets"
    ]
}